CHRNA2 Gene Epilepsy nocturnal frontal lobe type 4 Genetic Test sale cost 4400 AED
SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test sale cost 4400 AED SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CASK Gene FG Syndrome Type 4 Genetic Test sale cost 4400 AED CASK Gene FG Syndrome Type 4 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CHRNA2 Gene Epilepsy nocturnal frontal lobe type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the CHRNA2 gene, which have been linked to epilepsy nocturnal frontal lobe type 4 (ENFL4). ENFL4 is a rare form of epilepsy characterized by nocturnal seizures with frontal lobe origin, affecting individuals during sleep. The CHRNA2 gene plays a crucial role in the proper functioning of neuronal nicotinic acetylcholine receptors, which are essential for normal neurological activity. Mutations in this gene can disrupt normal brain activity, leading to the development of epilepsy.

The test is conducted through a detailed analysis of the patient’s DNA, extracted from a blood sample, to detect any genetic anomalies in the CHRNA2 gene. This genetic testing is pivotal for individuals with a family history of ENFL4 or those exhibiting symptoms, as it provides a definitive diagnosis, enabling targeted treatment and management of the condition.

The cost of the CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses of the genetic analysis, the expertise of the medical professionals involved, and the use of advanced laboratory technology to ensure accurate results. Undergoing this test at DNA Labs UAE offers patients access to state-of-the-art genetic testing services, with reliable results that can significantly impact the management and understanding of epilepsy nocturnal frontal lobe type 4.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test

Welcome to DNA Labs UAE, where we offer comprehensive genetic testing services. In this blog post, we will discuss the CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test, including its cost, symptoms, diagnosis, and other relevant information.

Test Details

The CHRNA2 gene is associated with epilepsy, specifically nocturnal frontal lobe epilepsy type 4 (NFLE4). NFLE4 is a rare form of epilepsy that causes seizures during sleep, usually in the first few hours of the night. The seizures are characterized by sudden, brief, and often violent movements, and can be difficult to diagnose.

Test Name: CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test

  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4.

NGS Technology

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that uses advanced technology to sequence large amounts of DNA quickly and accurately. This type of testing can be used to identify mutations or changes in the CHRNA2 gene that may be responsible for NFLE4. If a person is suspected of having NFLE4, they may undergo NGS genetic testing to determine if there are any mutations in the CHRNA2 gene that could be causing their seizures.

Importance of Genetic Testing

This information obtained from genetic testing can be used to guide treatment decisions and help predict the course of the disease. However, it is important to note that genetic testing is not always necessary or appropriate for everyone with epilepsy. Decisions about testing should be made in consultation with a healthcare provider who specializes in epilepsy.

At DNA Labs UAE, we prioritize providing accurate and reliable genetic testing services. If you suspect that you or a loved one may have CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4, consult with a neurologist and consider undergoing our CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test for a comprehensive diagnosis.

Test Name CHRNA2 Gene Epilepsy nocturnal frontal lobe type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CHRNA2 Gene Epilepsy, nocturnal frontal lobe type 4 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHRNA2 Gene Epilepsy, nocturnal frontal lobe type 4
Test Details

The CHRNA2 gene is associated with epilepsy, specifically nocturnal frontal lobe epilepsy type 4 (NFLE4). NFLE4 is a rare form of epilepsy that causes seizures during sleep, usually in the first few hours of the night. The seizures are characterized by sudden, brief, and often violent movements, and can be difficult to diagnose.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that uses advanced technology to sequence large amounts of DNA quickly and accurately. This type of testing can be used to identify mutations or changes in the CHRNA2 gene that may be responsible for NFLE4.

If a person is suspected of having NFLE4, they may undergo NGS genetic testing to determine if there are any mutations in the CHRNA2 gene that could be causing their seizures. This information can be used to guide treatment decisions and help predict the course of the disease.

It is important to note that genetic testing is not always necessary or appropriate for everyone with epilepsy, and decisions about testing should be made in consultation with a healthcare provider who specializes in epilepsy.

SKU: TEST-1351 Category:

Related products